Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion–negative rhabdomyosarcoma: A report from the Children's Oncology Group

Pediatric paired box 3:forkhead box protein O1 fusion–negative (PF–) rhabdomyosarcoma (RMS) represents a diverse spectrum of tumors with marked differences in histology, myogenic differentiation, and clinical behavior.

[1]  Marian Harris,et al.  Institutional implementation of clinical tumor profiling on an unselected cancer population. , 2016, JCI insight.

[2]  A. Wagers,et al.  Myogenic tumors in nevoid Basal cell carcinoma syndrome. , 2015, Journal of pediatric hematology/oncology.

[3]  R. Bronson,et al.  Distinct Malignant Behaviors of Mouse Myogenic Tumors Induced by Different Oncogenetic Lesions , 2015, Front. Oncol..

[4]  J. Khan,et al.  Rhabdomyosarcoma: current challenges and their implications for developing therapies. , 2014, Cold Spring Harbor perspectives in medicine.

[5]  G. Getz,et al.  Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. , 2014, Cancer discovery.

[6]  Heather L. Mulder,et al.  Targeting oxidative stress in embryonal rhabdomyosarcoma. , 2013, Cancer cell.

[7]  A. McMahon,et al.  Mutations in Hedgehog pathway genes in fetal rhabdomyomas , 2013, The Journal of pathology.

[8]  S. Schmid,et al.  Multifocal Adult Rhabdomyoma of the Head and Neck Manifestation in 7 Locations and Review of the Literature , 2013, Case reports in otolaryngology.

[9]  A. Sivachenko,et al.  Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.

[10]  B. Shehata,et al.  Unusual Presentation of Extracardiac Fetal Rhabdomyoma of the Larynx in a Pediatric Patient with Tuberous Sclerosis , 2013, Fetal and pediatric pathology.

[11]  A. Cohen,et al.  Cardiac rhabdomyomas in tuberous sclerosis patients: a case report and review of the literature. , 2012, Archives of cardiovascular diseases.

[12]  Larissa V Furtado,et al.  Premature Closure of the Foramen Ovale Secondary to Congenital Aortic Valvular Stenosis in a Stillborn , 2012, Fetal and pediatric pathology.

[13]  James R. Anderson,et al.  Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: A report from the Children's Oncology Group , 2011, Pediatric blood & cancer.

[14]  Christine M. Miller,et al.  Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells , 2011, Proceedings of the National Academy of Sciences.

[15]  Benjamin R Arenkiel,et al.  Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. , 2011, Cancer cell.

[16]  S. Fulda,et al.  Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma , 2010, Oncogene.

[17]  N. Terada,et al.  mTOR regulates skeletal muscle regeneration in vivo through kinase-dependent and kinase-independent mechanisms. , 2009, American journal of physiology. Cell physiology.

[18]  Douglas Losordo,et al.  Sonic hedgehog regulates angiogenesis and myogenesis during post‐natal skeletal muscle regeneration , 2009, Journal of cellular and molecular medicine.

[19]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[20]  O. Halevy,et al.  Sonic hedgehog promotes proliferation and differentiation of adult muscle cells: Involvement of MAPK/ERK and PI3K/Akt pathways. , 2007, Biochimica et biophysica acta.

[21]  Keith L Ligon,et al.  A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. , 2006, Cancer research.

[22]  J. Chae,et al.  Mutational analysis of TSC1 and TSC2 in Korean patients with tuberous sclerosis complex , 2006, Brain and Development.

[23]  L. Kindblom,et al.  Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development , 2006, The Journal of pathology.

[24]  M. Rosemann,et al.  Genetic mapping of a Ptch1-associated rhabdomyosarcoma susceptibility locus on mouse chromosome 2. , 2004, Genomics.

[25]  A. Walch,et al.  Analysis of the PTCH coding region in human rhabdomyosarcoma , 2002, Human mutation.

[26]  Jie Chen,et al.  The Mammalian Target of Rapamycin Regulates C2C12 Myogenesis via a Kinase-independent Mechanism* , 2001, The Journal of Biological Chemistry.

[27]  D. Parham.  Pathologic Classification of Rhabdomyosarcomas and Correlations with Molecular Studies , 2001, Modern Pathology.

[28]  P. Sorensen,et al.  Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: An Intergroup Rhabdomyosarcoma Study , 2000, Genes, chromosomes & cancer.

[29]  R. Kodet,et al.  Orbital rhabdomyosarcomas and related tumors in childhood: relationship of morphology to prognosis--an Intergroup Rhabdomyosarcoma study. , 1997, Medical and pediatric oncology.

[30]  G. Ellis,et al.  Fetal rhabdomyoma of the head and neck: a clinicopathologic and immunophenotypic study of 24 cases. , 1993, Human pathology.

[31]  G. Ellis,et al.  Adult rhabdomyoma of the head and neck: a clinicopathologic and immunophenotypic study. , 1993, Human pathology.

[32]  R. Kodet,et al.  Is fetal cellular rhabdomyoma an entity or a differentiated rhabdomyosarcoma.? A study of patients with rhabdomyoma of the tongue and sarcoma of the tongue enrolled in the intergroup rhabdomyosarcoma studies, I, II, and III , 1991, Cancer.

[33]  A. McMahon,et al.  Hedgehog-driven myogenic tumors recapitulate skeletal muscle cellular heterogeneity. , 2016, Experimental cell research.